Cost-Effectiveness Analysis of 10% Intravenous Immunoglobulin Compared With Plasma Exchange in Treatment of Children With Guillain–Barré Syndrome in Russia

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intravenous Immunoglobulins Versus Plasma Exchange in the Treatment of Guillain-Barré Syndrome

Critical Care
Critical CareIntensive Care Medicine
2009English

Immunoglobulin G Fc N-Glycosylation in Guillain-Barré Syndrome Treated With Intravenous Immunoglobulin

Clinical and Experimental Immunology
AllergyImmunology
2014English

Plasmapheresis Treatment in Guillain-Barré Syndrome: Potential Benefit Over Intravenous Immunoglobulin

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2010English

Guillain-Barré Syndrome: Surveillance and Cost of Treatment Strategies

The Lancet
Medicine
2017English

Uses of Intravenous Immunoglobulin: A 13-Year Evaluation of Guillain–Barré Syndrome in Fez, Morocco

Journal of Biology and Medicine
2017English

Macrohematuria in Guillain-Barré Syndrome After the Treatment With Intravenous Γ-Globulin. A Case Report.

Nihon Shoni Jinzobyo Gakkai Zasshi
1995English

Japanese Multicenter Clinical Trial of Intravenous Polyethylene Glycol-Treated Immunoglobulin and Comparison With Previous Clinical Trial of Sulfonated Immunoglobulin in Guillain-Barré Syndrome

Clinical and Experimental Neuroimmunology
NeuroscienceNeurologyImmunologyMicrobiology
2017English

Guillain-Barré Syndrome

2020English

Is a Second Cycle of Immunoglobulin Justified in Axonal Forms of Guillain-Barré Syndrome?

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy